Amarin Pharma, Inc. et al v. Hikma Pharmaceuticals USA Inc. et al
Plaintiff: Mochida Pharmaceutical Co.,Ltd., Amarin Pharmaceuticals Ireland Limited and Amarin Pharma, Inc.
Defendant: Hikma Pharmaceuticals PLC., Hikma Pharmaceuticals USA Inc. and Health Net, LLC
Case Number: 1:2020cv01630
Filed: November 30, 2020
Court: US District Court for the District of Delaware
Presiding Judge: Richard G Andrews
Referring Judge: Jennifer L Hall
Nature of Suit: Patent
Cause of Action: 35 U.S.C. § 271
Jury Demanded By: Plaintiff
Docket Report

This docket was last retrieved on January 4, 2022. A more recent docket listing may be available from PACER.

Date Filed Document Text
January 27, 2021 Opinion or Order Filing 20 OPENING BRIEF in Support re #19 MOTION to Dismiss for Failure to State a Claim, filed by Hikma Pharmaceuticals PLC., Hikma Pharmaceuticals USA Inc..Answering Brief/Response due date per Local Rules is 2/10/2021. (Gattuso, Dominick) Modified on 1/28/2021 (nms).
January 27, 2021 Opinion or Order Filing 19 MOTION to Dismiss for Failure to State a Claim - filed by Hikma Pharmaceuticals PLC., Hikma Pharmaceuticals USA Inc.. (Attachments: #1 Proposed Order)Motions referred to Jennifer L. Hall.(Gattuso, Dominick) Modified on 1/28/2021 (nms).
January 26, 2021 Opinion or Order Filing 18 SUMMONS Returned Executed by Amarin Pharmaceuticals Ireland Limited, Amarin Pharma, Inc., Mochida Pharmaceutical Co.,Ltd.. Health Net, LLC served on 1/26/2021, answer due 2/16/2021. (Anderson, Jeremy)
January 26, 2021 Opinion or Order Pro Hac Vice Attorney Claire A. Fundakowski for Hikma Pharmaceuticals PLC. and Hikma Pharmaceuticals USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
January 25, 2021 Opinion or Order Filing 17 First Amended Complaint for Patent Infringement against Hikma Pharmaceuticals PLC., Hikma Pharmaceuticals USA Inc., Health Net, LLC- filed by Amarin Pharmaceuticals Ireland Limited, Amarin Pharma, Inc., Mochida Pharmaceutical Co.,Ltd.. (Attachments: #1 Redline, #2 Exhibit A, #3 Exhibit B, #4 Exhibit C, #5 Exhibit D, #6 Exhibit E, #7 Exhibit F, #8 Exhibit G, #9 Exhibit H, #10 Exhibit I, #11 Exhibit J, #12 Exhibit K, #13 Exhibit L, #14 Exhibit M, #15 Exhibit N, #16 Exhibit O, #17 Exhibit P, #18 Exhibit Q, #19 Exhibit R, #20 Exhibit S, #21 Exhibit T, #22 Exhibit U, #23 Exhibit V, #24 Exhibit W, #25 Exhibit X, #26 Exhibit Y, #27 Exhibit Z, #28 Exhibit AA, #29 Exhibit BB, #30 Exhibit CC, #31 Exhibit DD, #32 Exhibit EE, #33 Exhibit FF, #34 Exhibit GG, #35 Exhibit HH, #36 Exhibit II)(Anderson, Jeremy) Modified on 1/26/2021 (nms).
January 13, 2021 Opinion or Order Filing 16 ORAL ORDER: The case is now referred to Magistrate Judge Jennifer L. Hall for all purposes through the case dispositive motion deadline. Ordered by Judge Richard G. Andrews on 1/13/2021. Motions referred to Jennifer L. Hall.(nms)
January 11, 2021 Opinion or Order Filing 15 STIPULATION to Extend Time - filed by Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited, Mochida Pharmaceutical Co.,Ltd.. (Anderson, Jeremy) Modified on 1/11/2021 (nms).
January 11, 2021 Opinion or Order SO ORDERED, re #15 STIPULATION to Extend Time (*Reset Briefing Schedule: re #11 MOTION to Dismiss. Answering Brief due 2/2/2021, Reply Brief due 2/16/2021). Signed by Judge Richard G. Andrews on 1/11/2021. (nms)
January 5, 2021 Opinion or Order Filing 14 MOTION for Pro Hac Vice Appearance of Attorney Eimeric Reig-Plessis of Winston & Strawn LLP - filed by Hikma Pharmaceuticals PLC., Hikma Pharmaceuticals USA Inc.. (Gattuso, Dominick)
January 5, 2021 Opinion or Order SO ORDERED, re #14 MOTION for Pro Hac Vice Appearance of Attorney Eimeric Reig-Plessis of Winston & Strawn LLP, filed by Hikma Pharmaceuticals USA Inc., Hikma Pharmaceuticals PLC.. Signed by Judge Richard G. Andrews on 1/5/2021. (nms)
January 5, 2021 Opinion or Order Pro Hac Vice Attorney Eimeric Reig-Plessis for Hikma Pharmaceuticals PLC. and Hikma Pharmaceuticals USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
January 4, 2021 Opinion or Order Filing 13 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Hikma Pharmaceuticals, PLC for Hikma Pharmaceuticals USA Inc. filed by Hikma Pharmaceuticals PLC., Hikma Pharmaceuticals USA Inc.. (Gattuso, Dominick)
January 4, 2021 Opinion or Order Filing 12 OPENING BRIEF in Support re #11 MOTION to Dismiss for Failure to State a Claim Under Fed. R. Civ. P. 12(B)(6), filed by Hikma Pharmaceuticals PLC., Hikma Pharmaceuticals USA Inc..Answering Brief/Response due date per Local Rules is 1/19/2021. (Gattuso, Dominick) Modified on 1/5/2021 (nms).
January 4, 2021 Opinion or Order Filing 11 MOTION to Dismiss for Failure to State a Claim Under Fed. R. Civ. P. 12(B)(6) - filed by Hikma Pharmaceuticals PLC., Hikma Pharmaceuticals USA Inc.. (Attachments: #1 Proposed Order)(Gattuso, Dominick) Modified on 1/5/2021 (nms).
December 9, 2020 Opinion or Order Pro Hac Vice Attorney Charles B. Klein for Hikma Pharmaceuticals PLC. and Hikma Pharmaceuticals USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
December 9, 2020 Opinion or Order SO ORDERED, re #10 MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Claire A. Fundakowski, and Alison M. Heydorn of Winston & Strawn LLP, filed by Hikma Pharmaceuticals USA Inc., Hikma Pharmaceuticals PLC.. Signed by Judge Richard G. Andrews on 12/9/2020. (nms)
December 8, 2020 Opinion or Order Filing 10 MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Claire A. Fundakowski, and Alison M. Heydorn of Winston & Strawn LLP - filed by Hikma Pharmaceuticals PLC., Hikma Pharmaceuticals USA Inc.. (Gattuso, Dominick)
December 8, 2020 Opinion or Order Filing 9 STIPULATION TO EXTEND TIME Answer to Complaint to February 22, 2021 - filed by Hikma Pharmaceuticals PLC., Hikma Pharmaceuticals USA Inc.. (Gattuso, Dominick)
December 8, 2020 Opinion or Order Filing 8 NOTICE of Appearance by Dominick T. Gattuso on behalf of Hikma Pharmaceuticals PLC., Hikma Pharmaceuticals USA Inc. (Gattuso, Dominick)
December 8, 2020 Opinion or Order Filing 7 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Mochida Pharmaceutical Co.,Ltd.. (Anderson, Jeremy)
December 8, 2020 Opinion or Order Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Amarin Corporation plc for Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited filed by Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Anderson, Jeremy)
December 8, 2020 Opinion or Order SO ORDERED, re #9 STIPULATION and Order (*Reset Answer Deadlines: Hikma Pharmaceuticals PLC. answer due 2/22/2021; Hikma Pharmaceuticals USA Inc. answer due 2/22/2021). Signed by Judge Richard G. Andrews on 12/8/2020. (nms)
December 2, 2020 Opinion or Order Filing 5 SUMMONS Returned Executed by Amarin Pharmaceuticals Ireland Limited, Amarin Pharma, Inc., Mochida Pharmaceutical Co.,Ltd.. Hikma Pharmaceuticals USA Inc. served on 12/1/2020, answer due 12/22/2020. (Anderson, Jeremy)
December 2, 2020 Opinion or Order Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
November 30, 2020 Opinion or Order Filing 4 Summonses Issued (please complete the top portion of the form and print out for use/service). (apk)
November 30, 2020 Opinion or Order Filing 3 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,700,537 ;US 8,642,077 ;US 10,568,861. (apk)
November 30, 2020 Opinion or Order Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk)
November 30, 2020 Opinion or Order Filing 1 COMPLAINT filed with Jury Demand against Hikma Pharmaceuticals PLC., Hikma Pharmaceuticals USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3364424.) - filed by Amarin Pharmaceuticals Ireland Limited, Amarin Pharma, Inc., Mochida Pharmaceutical Co.,Ltd.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I, #10 Exhibit J, #11 Exhibit K, #12 Exhibit L, #13 Exhibit M, #14 Exhibit N, #15 Exhibit O, #16 Exhibit P, #17 Exhibit Q, #18 Exhibit R, #19 Exhibit S, #20 Exhibit T, #21 Exhibit U, #22 Exhibit V, #23 Exhibit W, #24 Exhibit X, #25 Exhibit Y, #26 Exhibit Z, #27 Exhibit AA, #28 Exhibit BB, #29 Civil Cover Sheet)(apk)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Amarin Pharma, Inc. et al v. Hikma Pharmaceuticals USA Inc. et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Mochida Pharmaceutical Co.,Ltd.
Represented By: Jeremy Douglas Anderson
Represented By: Elizabeth M. Flanagan
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Amarin Pharmaceuticals Ireland Limited
Represented By: Jeremy Douglas Anderson
Represented By: Elizabeth M. Flanagan
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Amarin Pharma, Inc.
Represented By: Jeremy Douglas Anderson
Represented By: Elizabeth M. Flanagan
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Hikma Pharmaceuticals PLC.
Represented By: Dominick T. Gattuso
Represented By: Charles B. Klein
Represented By: Claire A. Fundakowski
Represented By: Eimeric Reig-Plessis
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Hikma Pharmaceuticals USA Inc.
Represented By: Dominick T. Gattuso
Represented By: Charles B. Klein
Represented By: Claire A. Fundakowski
Represented By: Eimeric Reig-Plessis
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Health Net, LLC
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?